Inozyme Net Debt from 2010 to 2024

INZY Stock  USD 4.44  0.11  2.54%   
Inozyme PharmaInc Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Inozyme PharmaInc minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2010-12-31
Previous Quarter
12 M
Current Value
12.6 M
Quarterly Volatility
37.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Inozyme PharmaInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inozyme main balance sheet or income statement drivers, such as Net Interest Income of 4.3 M, Interest Income of 4.3 M or Depreciation And Amortization of 1.4 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.65. Inozyme financial statements analysis is a perfect complement when working with Inozyme PharmaInc Valuation or Volatility modules.
  
This module can also supplement Inozyme PharmaInc's financial leverage analysis and stock options assessment as well as various Inozyme PharmaInc Technical models . Check out the analysis of Inozyme PharmaInc Correlation against competitors.
For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme PharmaInc guide.

Latest Inozyme PharmaInc's Net Debt Growth Pattern

Below is the plot of the Net Debt of Inozyme PharmaInc over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Inozyme PharmaInc's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inozyme PharmaInc's overall financial position and show how it may be relating to other accounts over time.
Net Debt10 Years Trend
Pretty Stable
   Net Debt   
       Timeline  

Inozyme Net Debt Regression Statistics

Arithmetic Mean(35,692,120)
Coefficient Of Variation(106.09)
Mean Deviation16,717,573
Median(35,966,000)
Standard Deviation37,865,048
Sample Variance1433.8T
Range171.2M
R-Value0.16
Mean Square Error1504T
R-Squared0.03
Significance0.57
Slope1,363,691
Total Sum of Squares20072.7T

Inozyme Net Debt History

202412.6 M
202312 M
2022-26.1 M
2021-19.9 M
2020-158.6 M
2019-31.6 M

Other Fundumenentals of Inozyme PharmaInc

Inozyme PharmaInc Net Debt component correlations

0.980.97-0.05-0.880.740.781.00.94-0.630.870.991.01.00.820.820.78-0.770.790.67-0.51
0.981.0-0.16-0.830.850.670.970.93-0.790.820.990.960.960.730.880.76-0.750.760.51-0.41
0.971.0-0.18-0.810.860.630.970.91-0.790.820.990.960.950.70.880.76-0.740.750.48-0.37
-0.05-0.16-0.18-0.38-0.420.32-0.030.170.350.02-0.080.0-0.010.42-0.030.46-0.50.490.49-0.49
-0.88-0.83-0.81-0.38-0.57-0.89-0.89-0.970.49-0.8-0.86-0.9-0.89-0.97-0.73-0.890.94-0.93-0.780.75
0.740.850.86-0.42-0.570.350.730.74-0.950.640.780.70.690.440.820.5-0.550.520.04-0.18
0.780.670.630.32-0.890.350.780.84-0.230.690.720.80.810.940.50.61-0.70.690.9-0.9
1.00.970.97-0.03-0.890.730.780.94-0.630.890.991.01.00.810.840.8-0.780.80.67-0.51
0.940.930.910.17-0.970.740.840.94-0.670.820.940.940.940.920.830.85-0.90.890.67-0.68
-0.63-0.79-0.790.350.49-0.95-0.23-0.63-0.67-0.44-0.71-0.6-0.59-0.37-0.81-0.480.54-0.50.030.14
0.870.820.820.02-0.80.640.690.890.82-0.440.840.870.870.680.780.76-0.720.750.54-0.38
0.990.990.99-0.08-0.860.780.720.990.94-0.710.840.990.990.780.860.79-0.770.790.61-0.46
1.00.960.960.0-0.90.70.81.00.94-0.60.870.991.00.840.810.8-0.780.810.7-0.53
1.00.960.95-0.01-0.890.690.811.00.94-0.590.870.991.00.830.80.79-0.770.790.71-0.53
0.820.730.70.42-0.970.440.940.810.92-0.370.680.780.840.830.570.78-0.860.850.85-0.86
0.820.880.88-0.03-0.730.820.50.840.83-0.810.780.860.810.80.570.78-0.790.770.35-0.33
0.780.760.760.46-0.890.50.610.80.85-0.480.760.790.80.790.780.78-0.960.990.61-0.44
-0.77-0.75-0.74-0.50.94-0.55-0.7-0.78-0.90.54-0.72-0.77-0.78-0.77-0.86-0.79-0.96-0.99-0.620.61
0.790.760.750.49-0.930.520.690.80.89-0.50.750.790.810.790.850.770.99-0.990.65-0.56
0.670.510.480.49-0.780.040.90.670.670.030.540.610.70.710.850.350.61-0.620.65-0.8
-0.51-0.41-0.37-0.490.75-0.18-0.9-0.51-0.680.14-0.38-0.46-0.53-0.53-0.86-0.33-0.440.61-0.56-0.8
Click cells to compare fundamentals

About Inozyme PharmaInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Inozyme PharmaInc income statement, its balance sheet, and the statement of cash flows. Inozyme PharmaInc investors use historical funamental indicators, such as Inozyme PharmaInc's Net Debt, to determine how well the company is positioned to perform in the future. Although Inozyme PharmaInc investors may use each financial statement separately, they are all related. The changes in Inozyme PharmaInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Inozyme PharmaInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Inozyme PharmaInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Inozyme PharmaInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Debt12 M12.6 M
Net Debt To EBITDA(0.16)(0.15)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Inozyme PharmaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inozyme PharmaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inozyme Pharmainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inozyme Pharmainc Stock:
Check out the analysis of Inozyme PharmaInc Correlation against competitors.
For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme PharmaInc guide.
Note that the Inozyme PharmaInc information on this page should be used as a complementary analysis to other Inozyme PharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Inozyme Stock analysis

When running Inozyme PharmaInc's price analysis, check to measure Inozyme PharmaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme PharmaInc is operating at the current time. Most of Inozyme PharmaInc's value examination focuses on studying past and present price action to predict the probability of Inozyme PharmaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme PharmaInc's price. Additionally, you may evaluate how the addition of Inozyme PharmaInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Inozyme PharmaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inozyme PharmaInc. If investors know Inozyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inozyme PharmaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.37)
Return On Assets
(0.28)
Return On Equity
(0.55)
The market value of Inozyme PharmaInc is measured differently than its book value, which is the value of Inozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Inozyme PharmaInc's value that differs from its market value or its book value, called intrinsic value, which is Inozyme PharmaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inozyme PharmaInc's market value can be influenced by many factors that don't directly affect Inozyme PharmaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inozyme PharmaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inozyme PharmaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inozyme PharmaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.